Novel in Vitro-in Vivo Extrapolation (IVIVE) Method to Predict Hepatic Organ Clearance in Rat

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2011 Oct 21

PMID 22011931

Citations 12

Authors

Ken-Ichi Umehara

Gian Camenisch

Affiliations

Soon will be listed here.

Abstract

Purpose: Drug elimination in the liver consists of uptake, metabolism, biliary excretion, and sinusoidal efflux from the hepatocytes to the blood. We aimed to establish an accurate prediction method for liver clearance in rats, considering these four elimination processes. In vitro assays were combined to achieve improved predictions.

Methods: In vitro clearances for uptake, metabolism, biliary excretion and sinusoidal efflux were determined for 13 selected compounds with various physicochemical and pharmacokinetic properties. Suspended hepatocytes, liver microsomes and sandwich-cultured hepatocytes were evaluated as in vitro models. Based on the individual processes, in vivo hepatic clearance was calculated. Subsequently, the predicted clearances were compared with the corresponding in vivo values from literature.

Results: Using this in vitro-in vivo extrapolation method good linear correlation was observed between predicted and reported clearances. Linear regression analysis revealed much improved prediction for the novel method (r(2) = 0.928) as compared to parameter analysis using hepatocyte uptake only (r(2) = 0.600), microsomal metabolism only (r(2) = 0.687) or overall hepatobiliary excretion in sandwich-cultured hepatocytes (r(2) = 0.321).

Conclusions: In this new attempt to predict hepatic elimination under consideration of multiple clearance processes, in vivo hepatic clearances of 13 compounds in rats were well predicted using an IVIVE analysis method based on in vitro assays.

Citing Articles

Simplifying the Extended Clearance Concept Classification System (EC3S) to Guide Clearance Prediction in Drug Discovery.

Patel M, Riede J, Bednarczyk D, Poller B, Deshmukh S Pharm Res. 2023; 40(4):937-949.

PMID: 36859748 DOI: 10.1007/s11095-023-03482-4.

RAID: Regression Analysis-Based Inductive DNA Microarray for Precise Read-Across.

Amano Y, Yamane M, Honda H Front Pharmacol. 2022; 13:879907.

PMID: 35935858 PMC: 9354856. DOI: 10.3389/fphar.2022.879907.

Recent developments in and models for improved translation of preclinical pharmacokinetics and pharmacodynamics data.

Yadav J, El Hassani M, Sodhi J, Lauschke V, Hartman J, Russell L Drug Metab Rev. 2021; 53(2):207-233.

PMID: 33989099 PMC: 8381685. DOI: 10.1080/03602532.2021.1922435.

Successful and Unsuccessful Prediction of Human Hepatic Clearance for Lead Optimization.

Sodhi J, Benet L J Med Chem. 2021; 64(7):3546-3559.

PMID: 33765384 PMC: 8504179. DOI: 10.1021/acs.jmedchem.0c01930.

A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies.

Serras A, Rodrigues J, Cipriano M, Rodrigues A, Oliveira N, Miranda J Front Cell Dev Biol. 2021; 9:626805.

PMID: 33732695 PMC: 7957963. DOI: 10.3389/fcell.2021.626805.

References

Li N, Singh P, Mandrell K, Lai Y . Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters. Mol Pharm. 2010; 7(3):630-41. DOI: 10.1021/mp9001574. View

Black A, Hayes R, Roth B, Woo P, Woolf T . Metabolism and excretion of atorvastatin in rats and dogs. Drug Metab Dispos. 1999; 27(8):916-23. View

Lee J, Marion T, Abe K, Lim C, Pollock G, Brouwer K . Hepatobiliary disposition of troglitazone and metabolites in rat and human sandwich-cultured hepatocytes: use of Monte Carlo simulations to assess the impact of changes in biliary excretion on troglitazone sulfate accumulation. J Pharmacol Exp Ther. 2009; 332(1):26-34. PMC: 2802476. DOI: 10.1124/jpet.109.156653. View

Fukuda H, Ohashi R, Tsuda-Tsukimoto M, Tamai I . Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes. Drug Metab Dispos. 2008; 36(7):1275-82. DOI: 10.1124/dmd.107.019026. View

Kalliokoski A, Niemi M . Impact of OATP transporters on pharmacokinetics. Br J Pharmacol. 2009; 158(3):693-705. PMC: 2765590. DOI: 10.1111/j.1476-5381.2009.00430.x. View

Tanaka C, Kawai R, Rowland M . Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues. Drug Metab Dispos. 2000; 28(5):582-9. View

Watanabe T, Kusuhara H, Maeda K, Shitara Y, Sugiyama Y . Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther. 2008; 328(2):652-62. DOI: 10.1124/jpet.108.146647. View

Treijtel N, van Eijkeren J, Nijmeijer S, de Greef-van der Sandt I, Freidig A . Clearance and clearance inhibition of the HIV-1 protease inhibitors ritonavir and saquinavir in sandwich-cultured rat hepatocytes and rat microsomes. Toxicol In Vitro. 2008; 23(1):185-93. DOI: 10.1016/j.tiv.2008.11.001. View

Iwatsubo T, Hirota N, Ooie T, Suzuki H, Shimada N, Chiba K . Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol Ther. 1997; 73(2):147-71. DOI: 10.1016/s0163-7258(96)00184-2. View

10.

Mano Y, Usui T, Kamimura H . Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes. Drug Metab Dispos. 2007; 35(4):602-6. DOI: 10.1124/dmd.106.014225. View

11.

Rane A, Wilkinson G, SHAND D . Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. J Pharmacol Exp Ther. 1977; 200(2):420-4. View

12.

Harrison L, Gibaldi M . Pharmacokinetics of digoxin in the rat. Drug Metab Dispos. 1976; 4(1):88-93. View

13.

Letendre L, Scott M, Dobson G, Hidalgo I, Aungst B . Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction. Pharm Res. 2004; 21(8):1457-62. DOI: 10.1023/b:pham.0000036921.87928.72. View

14.

Lombardo F, Obach R, Shalaeva M, Gao F . Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. J Med Chem. 2004; 47(5):1242-50. DOI: 10.1021/jm030408h. View

15.

Veau C, Dautrey S, Tod M, Laouari D, Carbon C, Farinotti R . Influence of renal failure on ciprofloxacin pharmacokinetics in rats. Antimicrob Agents Chemother. 1998; 42(2):289-92. PMC: 105402. DOI: 10.1128/AAC.42.2.289. View

16.

Bhatti M, Foster R . Pharmacokinetics of the enantiomers of verapamil after intravenous and oral administration of racemic verapamil in a rat model. Biopharm Drug Dispos. 1997; 18(5):387-96. DOI: 10.1002/(sici)1099-081x(199707)18:5<387::aid-bdd26>3.0.co;2-x. View

17.

Bergeron M, Gennari F, Barza M, WEINSTEIN L, Cortell S . Renal tubular transport of penicillin G and carbenicillin in the rat. J Infect Dis. 1975; 132(4):374-83. DOI: 10.1093/infdis/132.4.374. View

18.

Jorgensen L, van Beek J, Lund S, Schousboe A, Badolo L . Evidence of Oatp and Mdr1 in cryopreserved rat hepatocytes. Eur J Pharm Sci. 2006; 30(2):181-9. DOI: 10.1016/j.ejps.2006.11.003. View

19.

Bow D, Perry J, Miller D, Pritchard J, Brouwer K . Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes. Drug Metab Dispos. 2007; 36(1):198-202. PMC: 2645440. DOI: 10.1124/dmd.107.018200. View

20.

Swift B, Pfeifer N, Brouwer K . Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev. 2010; 42(3):446-71. PMC: 3097390. DOI: 10.3109/03602530903491881. View